Trial Profile
Phase II trial of ARQ 501 in patients with ovarian cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2012
Price :
$35
*
At a glance
- Drugs Beta lapachone (Primary) ; Taxanes
- Indications Ovarian cancer
- Focus Therapeutic Use
- 23 Jun 2006 New trial record.